title: HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.
abstract: Approximately 50% of cancer patients receive radiation treatment, either alone or in combination with other therapies. Tumor hypoxia has long been associated with resistance to radiation therapy. Moreover, the expression of hypoxia inducible factors HIF1alpha and/or HIF2alpha correlates with poor prognosis in many tumors. Recent evidence indicates that HIF1alpha expression can enhance radiation-induced apoptosis in cancer cells. We demonstrate here that HIF2alpha inhibition promotes tumor cell death and, in contrast to HIF1alpha, enhances the response to radiation treatment. Specifically, inhibiting HIF2alpha expression augments p53 activity, increases apoptosis, and reduces clonogenic survival of irradiated and non-irradiated cells. Moreover, HIF2alpha inhibition promotes p53-mediated responses by disrupting cellular redox homeostasis, thereby permitting reactive oxygen species (ROS) accumulation and DNA damage. These results correlate with altered p53 phosphorylation and target gene expression in untreated human tumor samples and show that HIF2alpha likely contributes to tumor cell survival including during radiation therapy.
authors.affiliation: Abramson Family Cancer Research Institute, Abramson Cancer Center, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Bertout
authors.forename: Amar J
authors.initials: AJ
authors.lastname: Majmundar
authors.forename: John D
authors.initials: JD
authors.lastname: Gordan
authors.forename: Jennifer C
authors.initials: JC
authors.lastname: Lam
authors.forename: Dara
authors.initials: D
authors.lastname: Ditsworth
authors.forename: Brian
authors.initials: B
authors.lastname: Keith
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Brown
authors.forename: Katherine L
authors.initials: KL
authors.lastname: Nathanson
authors.forename: M Celeste
authors.initials: MC
authors.lastname: Simon
mesh_terms: D051017:Apoptosis Regulatory Proteins / Q000378:metabolism; D051792:Basic Helix-Loop-Helix Proteins / Q000235:genetics / Q000378:metabolism*; D053148:Caspase 3 / Q000378:metabolism; D002453:Cell Cycle / Q000528:radiation effects; D016923:Cell Death / Q000528:radiation effects; D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D004249:DNA Damage; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000528:radiation effects; D006801:Humans; D015151:Immunoblotting; D008856:Microscopy, Fluorescence; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D034622:RNA Interference; D011839:Radiation, Ionizing; D017382:Reactive Oxygen Species / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000528:radiation effects; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D000099162:Endothelial PAS Domain-Containing Protein 1
chemical_list: D051017:Apoptosis Regulatory Proteins; D051792:Basic Helix-Loop-Helix Proteins; D053148:Caspase 3; D011518:Proto-Oncogene Proteins; D017382:Reactive Oxygen Species; D016159:Tumor Suppressor Protein p53; D000099162:Endothelial PAS Domain-Containing Protein 1; C438378:BBC3 protein, human
references.citation: Nature. 1999 May 20;399(6733):271-5
references.pmid: 10353251
references.citation: Nat Med. 2003 Jun;9(6):677-84
references.pmid: 12778166
references.citation: J Biol Chem. 2004 Oct 1;279(40):41975-84
references.pmid: 15280382
references.citation: Cell Cycle. 2008 Aug 15;7(16):2535-43
references.pmid: 18719376
references.citation: Curr Opin Genet Dev. 2007 Feb;17(1):71-7
references.pmid: 17208433
references.citation: Cancer Cell. 2005 Aug;8(2):131-41
references.pmid: 16098466
references.citation: J Cell Sci. 2006 Dec 15;119(Pt 24):5015-20
references.pmid: 17158908
references.citation: Mutat Res. 2005 Oct 15;578(1-2):23-32
references.pmid: 15998523
references.citation: Cancer Res. 2004 Mar 15;64(6):1951-8
references.pmid: 15026329
references.citation: Cell Death Differ. 2006 Jun;13(6):941-50
references.pmid: 16601750
references.citation: Nat Rev Cancer. 2008 Dec;8(12):967-75
references.pmid: 18987634
references.citation: Nat Rev Cancer. 2003 Oct;3(10):721-32
references.pmid: 13130303
references.citation: Mol Cell. 2006 May 5;22(3):395-405
references.pmid: 16678111
references.citation: PLoS Biol. 2003 Dec;1(3):E83
references.pmid: 14691554
references.citation: Nucleic Acids Res. 1998 Jan 1;26(1):205-13
references.pmid: 9399837
references.citation: Cancer Cell. 2008 Dec 9;14(6):435-46
references.pmid: 19061835
references.citation: Mol Cell Biochem. 1998 Dec;189(1-2):127-35
references.pmid: 9879663
references.citation: Nat Genet. 2003 Dec;35(4):331-40
references.pmid: 14608355
references.citation: Antioxid Redox Signal. 2008 Sep;10(9):1501-14
references.pmid: 18498225
references.citation: Mol Cell. 2005 Jan 7;17(1):11-21
references.pmid: 15629713
references.citation: Mol Cancer Res. 2006 Sep;4(9):601-5
references.pmid: 16940159
references.citation: Cancer Cell. 2005 Aug;8(2):99-110
references.pmid: 16098463
references.citation: Mol Cell Biol. 2005 Jul;25(13):5675-86
references.pmid: 15964822
references.citation: Mol Endocrinol. 2003 Jul;17(7):1344-55
references.pmid: 12714703
references.citation: Mol Cell. 2008 Dec 26;32(6):838-48
references.pmid: 19111663
references.citation: Biochem Biophys Res Commun. 2008 Oct 10;375(1):156-61
references.pmid: 18692482
references.citation: Cancer Res. 2002 Dec 15;62(24):7316-27
references.pmid: 12499275
references.citation: J Biol Chem. 2004 Apr 9;279(15):14871-8
references.pmid: 14744852
references.citation: Cancer Cell. 2006 Nov;10(5):413-23
references.pmid: 17097563
references.citation: Trends Immunol. 2003 Aug;24(8):449-55
references.pmid: 12909459
references.citation: Nature. 1998 Mar 26;392(6674):405-8
references.pmid: 9537326
references.citation: Cancer Cell. 2007 Apr;11(4):335-47
references.pmid: 17418410